MedTrace Logo

ANalgesic Efficacy and Safety of MOrphiNe Versus Methoxyflurane in Patients With Acute Myocardial Infarction

NCT04476173 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2023-09-11

No results posted yet for this study

Summary

The purpose of this study is to evaluate analgesic efficacy of inhaled methoxyflurane vs intravenous morphine in patients presenting with acute ST-elevation (STEMI) / non ST-elevation acute coronary syndrome (NSTE-ACS)

Conditions

  • ST Elevation Myocardial Infarction
  • Non ST Segment Elevation Acute Coronary Syndrome

Interventions

DRUG

Methoxyflurane - Penthrox

ACS patients who received inhaled methoxyflurane as analgesic treatment

DRUG

Morphine

ACS patients who received intravenous morphine as analgesic treatment

Sponsors & Collaborators

  • Collegium Medicum w Bydgoszczy

    lead OTHER

Principal Investigators

  • Jacek Kubica, Professor · Collegium Medicum w Bydgoszczy

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-06-01
Primary Completion
2024-06-30
Completion
2024-12-30

Countries

  • Poland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04476173 on ClinicalTrials.gov